RAAS inhibitors do not increase the risk of COVID-19

According to five new studies, therapy with angiotensin-converting enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs) is not associated with an increased risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or with an increased risk of severe disease or in...

Descripción completa

Detalles Bibliográficos
Autor principal: Fernández-Ruiz, Irene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Research Highlight
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243952/
https://www.ncbi.nlm.nih.gov/pubmed/32444693
http://dx.doi.org/10.1038/s41569-020-0401-0
_version_ 1783537492601864192
author Fernández-Ruiz, Irene
author_facet Fernández-Ruiz, Irene
author_sort Fernández-Ruiz, Irene
collection PubMed
description According to five new studies, therapy with angiotensin-converting enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs) is not associated with an increased risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or with an increased risk of severe disease or in-hospital death among patients with COVID-19.
format Online
Article
Text
id pubmed-7243952
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-72439522020-05-22 RAAS inhibitors do not increase the risk of COVID-19 Fernández-Ruiz, Irene Nat Rev Cardiol Research Highlight According to five new studies, therapy with angiotensin-converting enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs) is not associated with an increased risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or with an increased risk of severe disease or in-hospital death among patients with COVID-19. Nature Publishing Group UK 2020-05-22 2020 /pmc/articles/PMC7243952/ /pubmed/32444693 http://dx.doi.org/10.1038/s41569-020-0401-0 Text en © Springer Nature Limited 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Research Highlight
Fernández-Ruiz, Irene
RAAS inhibitors do not increase the risk of COVID-19
title RAAS inhibitors do not increase the risk of COVID-19
title_full RAAS inhibitors do not increase the risk of COVID-19
title_fullStr RAAS inhibitors do not increase the risk of COVID-19
title_full_unstemmed RAAS inhibitors do not increase the risk of COVID-19
title_short RAAS inhibitors do not increase the risk of COVID-19
title_sort raas inhibitors do not increase the risk of covid-19
topic Research Highlight
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243952/
https://www.ncbi.nlm.nih.gov/pubmed/32444693
http://dx.doi.org/10.1038/s41569-020-0401-0
work_keys_str_mv AT fernandezruizirene raasinhibitorsdonotincreasetheriskofcovid19

Ejemplares similares